JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (40)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harke, H.
Right arrow Articles by Harke, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harke, H.
Right arrow Articles by Harke, O.
Related Collections
Right arrow Pain
Right arrow Pharmacology
Anesth Analg 2001;92:488-495
© 2001 International Anesthesia Research Society


REGIONAL ANESTHESIA AND PAIN MEDICINE

The Response of Neuropathic Pain and Pain in Complex Regional Pain Syndrome I to Carbamazepine and Sustained-Release Morphine in Patients Pretreated with Spinal Cord Stimulation: A Double-Blinded Randomized Study

Henning Harke, MD, Peter Gretenkort, MD, Hans U. Ladleif, MD, Salah Rahman, MD, and Ole Harke

Department of Anesthesia and Pain Therapy, Klinikum Krefeld, Krefeld, Germany.

Address correspondence and reprint requests to Henning Harke, MD, Department of Anesthesia and Pain Therapy, Klinikum Krefeld, Lutherplatz 40, D-47805 Krefeld, Germany.

Forty-three patients with peripheral neuropathic pain, exclusively pain reduced by spinal cord stimulation (SCS), were switched into a painful state after SCS inactivation. This mode was used to assess the pain-relieving effect of carbamazepine (CMZ) and opioids in a double-blinded, placebo-controlled trial. In Phase 1, the patients were randomly allocated to receive either CMZ (600 mg/d) or placebo during an SCS-free period of 8 days. In Phase 2, after a CMZ elimination interval of 7 days, 38 patients received either sustained-release morphine (90 mg/d) or placebo for 8 days. In cases of intolerable pain, the patients were authorized to reactivate their SCS. The pain intensity was rated on a numeric analog scale. In 38 patients who completed Phase 1, significant delay in pain increase was observed in the CMZ group as compared with placebo (P = 0.038). In Phase 2, the trend observed with morphine was insignificant (P = 0.41). Two CMZ patients and one morphine patient showed complete pain relief and preferred to continue the medication. Thirty-five patients returned to SCS. We conclude that CMZ is effective in peripheral neuropathic pain. Morphine obviously requires larger individually titrated dosages than those used in this study for results to be adequately interpreted.

Implications: This study included patients with neuropathic pain suppressed by spinal cord stimulation (SCS). After deactivation of SCS, different drug effects were evaluated. In contrast to morphine, carbamazepine showed significant pain relief compared with placebo.




This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
S. D. Passik
Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions
Mayo Clin. Proc., July 1, 2009; 84(7): 593 - 601.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Kozer, Z. Levichek, N. Hoshino, B. Kapur, J. Leombruno, N. Taguchi, F. Garcia-Bournissen, G. Koren, and S. Ito
The Effect of Amitriptyline, Gabapentin, and Carbamazepine on Morphine-Induced Hypercarbia in Rabbits
Anesth. Analg., October 1, 2008; 107(4): 1216 - 1222.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Katz
Methodological issues in clinical trials of opioids for chronic pain
Neurology, December 29, 2005; 65(12_suppl_4): S32 - S49.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. Eisenberg, E. D. McNicol, and D. B. Carr
Efficacy and Safety of Opioid Agonists in the Treatment of Neuropathic Pain of Nonmalignant Origin: Systematic Review and Meta-analysis of Randomized Controlled Trials
JAMA, June 22, 2005; 293(24): 3043 - 3052.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Harke, P. Gretenkort, H. U. Ladleif, P. Koester, and S. Rahman
Spinal Cord Stimulation in Postherpetic Neuralgia and in Acute Herpes Zoster Pain
Anesth. Analg., March 1, 2002; 94(3): 694 - 700.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. H. Hord, D. D. Denson, and M. I. Azevedo
Systemic Tizanidine Hydrochloride (ZanaflexTM) Partially Decreases Experimental Postoperative Pain in Rats
Anesth. Analg., November 1, 2001; 93(5): 1307 - 1309.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2001 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.